20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

Go back to 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
(NASDAQ: AIDX) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High
Open $0.61    52 Week Low
Day High $0.61    P/E N/A 
Day Low $0.61    EPS
Volume 20,243